Efficacy and safety of reperfusion therapy for ST-segment elevation myocardial infarction in patients older than 75 years
https://doi.org/10.37586/2686-8636-1-2023-39-43
Abstract
The review analyzes studies on the efficacy and safety of reperfusion therapy for ST-segment elevation myocardial infarction in patients over 75 years of age. Registers data on the positive impact of reperfusion treatments on outcomes in older patients hospitalized with STEMI are given. Particular emphasis is put on the need for prospective studies to determine the optimal tactics for managing older and oldest older patients with STEMI.
About the Authors
P. D. DuplyakovaRussian Federation
Duplyakova Polina D., PhD student, Cardiology and
Cardiovascular Surgery Department
Samara
T. V. Pavlova
Russian Federation
Pavlova Tatyana V., MD, PhD, professor, Cardiology and
Cardiovascular Surgery Department
Samara
D. V. Duplyakov
Russian Federation
Duplyakov Dmitry V., MD, PhD, professor, Medical Director
at Samara Regional Clinical Cardiological Dispensary; Head of the Internal Diseases Department, Samara State Medical University of the Ministry of Health of the Russian Federation
Samara
References
1. Oganov R.G., Gerasimenko N.F., Pogosova G.V., Koltunov I.E. Cardiovascular prevention: development strategies. Cardiovascular Therapy and Prevention. 2011;10(3):5-7. (In Russ.). https://doi. org/10.15829/1728-8800-2011-3-5-7
2. Данные Росста на 22.06.2019. URL: https://www.gsk.ru
3. Russian Society of Cardiology (. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.). doi:10.15829/1560-4071-2020- 4103
4. Borja Ibanez, Stefan James, Stefan Agewall et all. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
5. O. Manfrini, M. Dorobantu, Z. Vasiljevic et al. Acute coronary syndrome in octogenarian patients: results from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC) registry. Eur Heart J. 2014;16:87–94. https://doi. org/10.1093/eurheartj/sut019
6. Toleva O, Ibrahim Q, Brass N. et al. Treatment choices in elderly patients with ST: elevation myocardial infarction— insights from the Vital Heart Response registry. Open Heart J. 2015;2:e000235. doi: 10.1136/openhrt-2014-000235
7. de Boer M-J, Ottervanger J-P, van’t Hof AWJ. et al; Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723–1728. doi:10.1016/s0735-1097(02)01878-8.
8. https://www.acc.org/latest-in-cardiology/clinical-trials/ 2010/02/23/19/21/senior-pami
9. Bueno H, Betriu A, Heras M. et all. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardioeNAncianos) randomized trial and pooled analysis with previous studies. Eur Heart J. 2011;32:51–60. doi: 10.1093/eurheartj/ehq375.
10. Elbadawi A, Elgendy IY, Ha LD. et all. National trends of percutaneous coronary intervention in patients >_70 years of age. Am J Cardiol. 2019;123(1):25-32. doi: 10.1016/j. amjcard.2018.09.030.
11. Puymirat E, Aissaoui N, Cayla G. et all FAST-MI investigators. Changes in one-year mortality in elderly patients admitted with acute myocardial infarction in relation with early management. Am J Med. 2017;130:555–563. doi: 10.1016/j.amjmed.2016.12.005.
12. De Luca L, Olivari Z, Bolognese L. et all. A decade of changes in clinical characteristics and management of elderly patients with non-ST elevation myocardial infarction admitted in Italian cardiac care units. Open Heart. 2014;1:e000148. doi: 10.1136/ openhrt-2014-000148.
13. Forman DE, Chen AY, Wiviott SD. et all. Comparison of outcomes in patients aged 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG). Am J Cardiol. 2010;106:1382–1388. doi: 10.1016/j.amjcard.2015.09.022.
14. Caˆlmaˆc L, Bataila V, Ricci B. et al. Factors associated with use of percutaneous coronary intervention among elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI): results from the ISACS-TC registry. Int J Cardiol.2016;217:S21–S26. doi: 10.1016/j.ijcard.2016.06.227.
15. Pek PP, Zheng HZ, Ho WAF. et all. Comparison of epidemiology, treatments and outcomes of ST segment elevation myocardial infarction between young and elderly patients. Emerg Med J. 2018;35(5):289–296. doi: 10.1136/ emermed-2017-206754
Review
For citations:
Duplyakova P.D., Pavlova T.V., Duplyakov D.V. Efficacy and safety of reperfusion therapy for ST-segment elevation myocardial infarction in patients older than 75 years. Russian Journal of Geriatric Medicine. 2023;(1):39-43. (In Russ.) https://doi.org/10.37586/2686-8636-1-2023-39-43